SOPHiA GENETICS (SOPH) CFO George Cardoza Sells 1,592 Shares

What Happened
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 1,592 shares in an open-market transaction on July 6, 2026. The reported weighted average sale price was $5.29 per share (range $4.97–$5.43), for proceeds of approximately $8,419. The sale was made to satisfy tax withholding obligations arising from restricted stock units that vested on July 2, 2026.

Key Details

• Transaction date: 2026-07-06 (reported on Form 4 filed 2026-07-07) — appears timely.
• Shares sold: 1,592; weighted average price: $5.29; price range: $4.97–$5.43. Total proceeds ≈ $8,419.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnotes: Sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan and done to satisfy tax withholding on RSU vesting (non-discretionary). The filer can provide a breakdown of shares sold at each price within the stated range upon request.

Context
This was a routine, tax-withholding sale tied to RSU vesting and executed under a 10b5-1 plan, which is common and generally less informative about an insider’s view of the company than open-market purchases. The weighted-average price reflects multiple executions during the same day.